Seegnal’s Investor Meet & Greet with Corporate CEO, Mr. Elad Bibi-Aviv
(TSXV: SEGN), a global leader in clinical decision support solutions applying patient-centric medication safety standards, today announced that its Chief Executive Officer, Elad Bibi-Aviv, will host two virtual investor meetings on January 19, 2026. These online sessions will provide shareholders with an opportunity to meet Mr. Bibi-Aviv personally and hear his vision for Seegnal’s future.
